Overview
Nucleotide ID | | c.1102_1137delinsCA |
| | |
Protein ID | | p.K368Qfs*51 |
| | |
Mutation | | Deletion+Insertion |
| | |
Type | | Type 1-like |
| | |
Class | | Class A |
| | |
Category | | Type 16 |
COSMIC | | COSV57120754 |
| | |
Pathologie | | Essential thrombocythaemia |
Structure
# PSIPRED HFORMAT (PSIPRED V4.0)
Conf: 935765137679999999999999999999999999999999994499999954999998
Pred: CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
AA: AAEKQMKDKQDEEQRLQRRQRTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACL
10 20 30 40 50 60
Conf: 535139
Pred: HHHHCC
AA: QGWTEA
References
PMID | Citation |
---|
32395211 | Liu YC, Lee CP, Yeh TJ, et al. Calreticulin Mutation Survey by High Resolution Melting Method Associated with Unique Presentations in Essential Thrombocythemic Patients. Mediterr J Hematol Infect Dis. 2020.12(1):e2020022. Published 2020 May 1. doi:10.4084/MJHID.2020.022 |
24325356 | Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013.369(25):2379-2390. doi:10.1056/NEJMoa1311347 |
24366362 | Rumi E, Pietra D, Ferretti V, et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014.123(10):1544-1551. doi:10.1182/blood-2013-11-539098 |
29424450 | Lasho TL, Finke CM, Tischer A, Pardanani A, Tefferi A. Mayo CALR mutation type classification guide using alpha helix propensity. Am J Hematol. 2018.93(5):E128-E129. doi:10.1002/ajh.25065 |